Proceedings of the National Academy of Sciences · 1978 · 216 citations · 24 references
MedicineNeurobiologyPharmacologyBiochemical PharmacologyMolecular PharmacologyNeuropharmacologyBinding KineticsDrug-receptor InteractionsLigand BindingLigand Binding KineticsReceptor PharmacologyReceptor-ligand InteractionsDrug Receptor Binding DynamicsDrug Receptor KineticsLigand DissociationLigand-receptor KineticsOpioid Receptor BindingPharmacodynamics Of Neuroactive DrugsReceptor Binding ModulationReceptors
This study shows that nucleotides, as well as ions, regulate the opiate receptors of brain. GMP-P(NH)P and Na(+) reduce the amount of steady-state specific [(3)H]dihydromorphine binding and increase the rate of dissociation of the ligand from the opiate receptor. In contrast, Mn(2+) decreases the rate of ligand dissociation and antagonizes the ability of Na(+) to increase dissociation. The effects of GMP-P(NH)P on steady-state binding and dissociation are not reversed by washing. Only GTP, GDP, ITP, and IMP-P(NH)P, in addition to GMP-P(NH)P, increase the rate of dihydromorphine dissociation. The site of nucleotide action appears to have high affinity: <1 muM GMP-P(NH)P produces half-maximal increases in ligand dissociation. GMP-P(NH)P- and Na(+)-directed increases in dissociation have also been found for the opiate agonists [(3)H]etorphine, [(3)H]Leu-enkephalin, and [(3)H]Met-enkephalin and the opiate antagonist [(3)H]naltrexone. Mn(2+)-directed decreases in dissociation have been found for the agonist [(3)H]-etorphine and the antagonist [(3)H]naltrexone. Although the plasma membrane receptors for a number of other neuro-transmitters and hormones are also regulated by guanine nucleotides, the opiate receptors appear unique because only they show nucleotide regulation of both agonist and antagonist binding.
24
Advances in Cyclic Nucleotide Research
Lutz Birnbaumer, Stephen L. Pohl, Martin Rodbell · Journal of Biological Chemistry · 1969 · 436 citations · Full text